Amarin Slides as Bulls Battle Bears After Fish-Oil Results

(Bloomberg) -- Full results for Amarin Corp.’s Vascepa fish-oil pill for high-risk cardiovascular patients exceeded sell-side expectations in a long-term study and re-ignited a bull versus bear deb...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.